NBRV - ナブリバ・セラピュ―ティクス (Nabriva Therapeutics plc) ナブリバ・セラピュ―ティクス

 NBRVのチャート


 NBRVの企業情報

symbol NBRV
会社名 Nabriva Therapeutics AG (ナブリバ・セラピュ―ティクス)
分野(sector) Health Care   ヘルスケア
産業(industry) Major Pharmaceuticals  
業種 バイオテクノロジ―_メディカルリサ―チ   医療関連(Health Care)
概要 事業概要 Nabriva Therapeutics plc is a clinical stage biopharmaceutical company. The Company is engaged in engaged in the research and development of novel anti-infectives to treat serious infections with a focus on the pleuromutilin class of antibiotics. The Company’s medicinal chemistry has enabled targeted discovery of novel pleuromutilins including both intravenous and oral formulations of its lead product candidate lefamulin. Lefamulin is a novel semi-synthetic pleuromutilin antibiotic with the potential to be the first-in-class available for systemic administration in humans. Lefamulin is being evaluated in two global registrational Phase III clinical trials in patients with moderate to severe community-acquired bacterial pneumonia (CABP).It seeks to further pursue development of lefamulin for additional indications including the treatment of acute bacterial skin and skin structure infections (ABSSSI) and is developing a formulation of lefamulin appropriate for pediatric use.   ナブリバ・セラピュ―ティクスはオ―ストリアのバイオ医薬品企業。臨床段階で、主に抗生物質プレウロムチリンに焦点を当て、感染症治療のための抗生物質の研究開発に従事する。市中感染性細菌性肺炎(CABP)の治療向け静脈点滴と経口投与薬を開発、また肺炎以外の疾患に対する有効性を研究。米国内ではペンシルベニア州に拠点を置く。本社はヴィエナ。   Nabriva Therapeutics is a biopharmaceutical company engaged in the commercialization and development of innovative anti-infective agents to treat serious infections. Nabriva Therapeutics received U.S. Food and Drug Administration approval for XENLETA® (lefamulin injection, lefamulin tablets), the first systemic pleuromutilin antibiotic for community-acquired bacterial pneumonia (CABP). Nabriva Therapeutics is also developing CONTEPO™ (fosfomycin) for injection, a potential first-in-class epoxide antibiotic for complicated urinary tract infections (cUTI), including acute pyelonephritis. Nabriva entered into an exclusive agreement with subsidiaries of Merck & Co. Inc., Kenilworth, N.J., USA to market, sell and distribute SIVEXTRO® (tedizolid phosphate) in the United States and certain of its territories.
本社所在地 Leberstrasse 20 Vienna 1110 AUT
代表者氏名 Daniel D. Burgess ダニエル・D・バージェス
代表者役職名 Independent Chairman of the Supervisory Board
電話番号
設立年月日 38626
市場名 NASDAQ National Market System
ipoyear 2015年
従業員数 59人
url www.nabriva.com
nasdaq_url https://www.nasdaq.com/symbol/nbrv
adr_tso
EBITDA EBITDA(百万ドル) -73.03200
終値(lastsale) 2.949
時価総額(marketcap) 196061784.891
時価総額 時価総額(百万ドル) 179.50720
売上高 売上高(百万ドル) 10.98800
企業価値(EV) 企業価値(EV)(百万ドル) 104.62120
当期純利益 当期純利益(百万ドル) -75.66100
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 Nabriva Therapeutics PLC - ADR revenues increased from $2.7M to $8.4M. Net loss increased 4% to $31.1M. Revenues reflect Government grants increase of 39% to $419K. Higher net loss reflects Interest income decrease of 88% to $28K (income) Interest Exp-Net of Capitalized Interest increase from $4K to $11K (expense) Other income (expense) net increase of 2% to $118K (expense).

 NBRVのテクニカル分析


 NBRVのニュース

   Nabriva Publishes Data Demonstrating the Potent Anti-Inflammatory Properties of XENLETA® (lefamulin)  2021/10/04 20:05:00 Intrado Digital Media
DUBLIN, Ireland and FORT WASHINGTON, Pa., Oct. 04, 2021 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical company engaged in the commercialization and development of innovative anti-infective agents to treat serious infections, today published the first data to demonstrate the anti-inflammatory activity of XENLETA ® (lefamulin).
   Nabriva Therapeutics hires Chief Medical Officer  2021/10/01 11:14:14 Seeking Alpha
   Nabriva Therapeutics Appoints Dr. Christine Guico-Pabia, M.D., as Chief Medical Officer  2021/10/01 11:01:00 Intrado Digital Media
DUBLIN, Ireland and FORT WASHINGTON, Pa., Oct. 01, 2021 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical company engaged in the commercialization and development of innovative anti-infective agents to treat serious infections, announced the appointment of Dr. Christine Guico-Pabia, M.D., MBA, MPH as Chief Medical Officer (CMO) effective October 1, 2021.
   Mind-blowing stocks: Nabriva Therapeutics plc (NASDAQ:NBRV 3.24%), Washington Prime Group Inc. (NYSE:WPG -1.16%)  2021/09/28 00:01:15 Stock Equity
There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 … The post Mind-blowing stocks: Nabriva Therapeutics plc (NASDAQ:NBRV 3.24%), Washington Prime Group Inc. (NYSE:WPG -1.16%) appeared first on Stocks Equity .
   Things You Didnt Know About: Nabriva Therapeutics plc (NASDAQ:NBRV -1.04%), Check-Cap Ltd. (NASDAQ:CHEK -0.50%)  2021/09/18 00:10:05 Stock Equity
There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 The post Things You Didnt Know About: Nabriva Therapeutics plc (NASDAQ:NBRV -1.04%), Check-Cap Ltd. (NASDAQ:CHEK -0.50%) appeared first on Stocks Equity .
   Investors must not feel shy to buy this Stock: Nabriva Therapeutics plc (NASDAQ:NBRV), Solitario Zinc Corp. (AMEX:XPL)  2021/06/27 23:24:53 Stock Equity
Nabriva Therapeutics plc (NBRV) with the stream of 2.17% also noticed, India Solitario Zinc Corp. (XPL) encountered a rapid change of -3.19% in the last hour of trading session. Nabriva The post Investors must not feel shy to buy this Stock: Nabriva Therapeutics plc (NASDAQ:NBRV), Solitario Zinc Corp. (AMEX:XPL) appeared first on Stocks Equity .
   Have an eye on: Nabriva Therapeutics plc (NASDAQ:NBRV), Zomedica Corp. (AMEX:ZOM)  2021/06/25 23:01:09 Stock Equity
Nabriva Therapeutics plc (NASDAQ:NBRV) with the stream of 1.45% also noticed, India Zomedica Corp. (AMEX:ZOM) encountered a rapid change of -0.71% in the last hour of Fridays trading session. Nabriva The post Have an eye on: Nabriva Therapeutics plc (NASDAQ:NBRV), Zomedica Corp. (AMEX:ZOM) appeared first on Stocks Equity .
   Top-notch Stock: Nabriva Therapeutics plc (NASDAQ:NBRV), Valaris Limited (NYSE:VAL)  2021/06/23 22:08:44 Stock Equity
Nabriva Therapeutics plc (NBRV) with the stream of -0.74% also noticed, India Valaris Limited (VAL) encountered a rapid change of 2.47% in the last hour of Wednesdays trading session. Nabriva The post Top-notch Stock: Nabriva Therapeutics plc (NASDAQ:NBRV), Valaris Limited (NYSE:VAL) appeared first on Stocks Equity .
   Analysts Recommendation in Spotlight- Nabriva Therapeutics plc (NASDAQ:NBRV) encountered the change of -4.29%  2021/06/20 22:24:34 Stock Equity
On Friday, Shares of Nabriva Therapeutics plc (NASDAQ:NBRV) reached at $1.34 price level during last trade its distance from 20 days simple moving average was -6.20%, and its distance from The post Analysts Recommendation in Spotlight- Nabriva Therapeutics plc (NASDAQ:NBRV) encountered the change of -4.29% appeared first on Stocks Equity .
   Analyzing Analysts Recommendations: Nabriva Therapeutics plc (NASDAQ:NBRV), Marathon Oil Corporation (NYSE:MRO)  2021/06/18 21:51:42 Stock Equity
Nabriva Therapeutics plc (NASDAQ:NBRV) with the stream of -4.48% also noticed, India Marathon Oil Corporation (NYSE:MRO) encountered a rapid change of -1.55% in the last hour of Fridays trading session. The post Analyzing Analysts Recommendations: Nabriva Therapeutics plc (NASDAQ:NBRV), Marathon Oil Corporation (NYSE:MRO) appeared first on Stocks Equity .
   Have an eye on: Nabriva Therapeutics plc (NASDAQ:NBRV), Zomedica Corp. (AMEX:ZOM)  2021/06/25 23:01:09 Stock Equity
Nabriva Therapeutics plc (NASDAQ:NBRV) with the stream of 1.45% also noticed, India Zomedica Corp. (AMEX:ZOM) encountered a rapid change of -0.71% in the last hour of Fridays trading session. Nabriva The post Have an eye on: Nabriva Therapeutics plc (NASDAQ:NBRV), Zomedica Corp. (AMEX:ZOM) appeared first on Stocks Equity .
   Top-notch Stock: Nabriva Therapeutics plc (NASDAQ:NBRV), Valaris Limited (NYSE:VAL)  2021/06/23 22:08:44 Stock Equity
Nabriva Therapeutics plc (NBRV) with the stream of -0.74% also noticed, India Valaris Limited (VAL) encountered a rapid change of 2.47% in the last hour of Wednesdays trading session. Nabriva The post Top-notch Stock: Nabriva Therapeutics plc (NASDAQ:NBRV), Valaris Limited (NYSE:VAL) appeared first on Stocks Equity .
   Analysts Recommendation in Spotlight- Nabriva Therapeutics plc (NASDAQ:NBRV) encountered the change of -4.29%  2021/06/20 22:24:34 Stock Equity
On Friday, Shares of Nabriva Therapeutics plc (NASDAQ:NBRV) reached at $1.34 price level during last trade its distance from 20 days simple moving average was -6.20%, and its distance from The post Analysts Recommendation in Spotlight- Nabriva Therapeutics plc (NASDAQ:NBRV) encountered the change of -4.29% appeared first on Stocks Equity .
   Analyzing Analysts Recommendations: Nabriva Therapeutics plc (NASDAQ:NBRV), Marathon Oil Corporation (NYSE:MRO)  2021/06/18 21:51:42 Stock Equity
Nabriva Therapeutics plc (NASDAQ:NBRV) with the stream of -4.48% also noticed, India Marathon Oil Corporation (NYSE:MRO) encountered a rapid change of -1.55% in the last hour of Fridays trading session. The post Analyzing Analysts Recommendations: Nabriva Therapeutics plc (NASDAQ:NBRV), Marathon Oil Corporation (NYSE:MRO) appeared first on Stocks Equity .
   Hedge Funds Never Been Less Bullish On Nabriva Therapeutics plc (NBRV)  2021/06/18 19:03:39 Insider Monkey

 関連キーワード  (バイオテクノロジ―_メディカルリサ―チ 米国株 ナブリバ・セラピュ―ティクス NBRV Nabriva Therapeutics plc)

 twitter  (公式ツイッターやCEOツイッターなど)